首页> 外文期刊>Molecular Biology >Association of Polymorphisms of Cytokine Genes (IL1B, IL1RN, TNFA, LTA, IL6, IL8, and IL10) with Chronic Obstructive Pulmonary Disease
【24h】

Association of Polymorphisms of Cytokine Genes (IL1B, IL1RN, TNFA, LTA, IL6, IL8, and IL10) with Chronic Obstructive Pulmonary Disease

机译:细胞因子基因(IL1B,IL1RN,TNFA,LTA,IL6,IL8和IL10)的多态性与慢性阻塞性肺疾病的关系

获取原文
获取原文并翻译 | 示例
           

摘要

To assess the role that polymorphisms of cytokine genes play in genetic predisposition to chronic obstructive pulmonary disease (COPD), the allele and genotype distributions of IL1B, IL1RN, TNFA, LTA, IL6, IL8, and IL10 were studied in COPD patients (N = 319) and healthy individuals (N = 403), residents of Ufa, Bashkortostan. Genotype IL1RN*2/IL1RN*2 of IL1RN was identified as a risk factor for COPD, its frequency being 9.80% in the COPD patients and 4.67% in the healthy subjects (chi~2 = 5.45, df= 1,P = 0.02, OR = 2.21). Genotype GG of the LTA polymorphism A252G was significantly more common in the COPD patients than in the controls (7.84% vs. 3.72%; chi~2 = 5.00, df= 1, P = 0.026). In patients with COPD stage IV, the frequency of this genotype was twice as high as in those with COPD stages II and III (11.18% vs. 4.79%; chi~2 = 3.08, df= 1, P = 0.08). Genotype GG of the TNFA polymorphism G(-308)A in combination with genotype AA of the LTA polymorphism A252G was significantly less frequent in the COPD patients than in the healthy subjects (38.55% vs. 46.93%; chi~2 = 8.82, df=1,P = 0.0039). Genotype GG of the IL6 polymorphism G(-174)C was more frequent in the patients with COPD stage IV (43.75% vs. 31.54% in the patients with COPD stages II and III, chi~2 = 4.15, P = 0.042). No significant differences were found between the groups of COPD patients and healthy subjects concerning the genotype frequencies of the polymorphisms T(-511)C and T3953C of IL1B, G(-308)A of TNFA, G(-174)C of IL6, A(-251)C of IL8, and C(-627)A of IL10.
机译:为了评估细胞因子基因多态性在慢性阻塞性肺疾病(COPD)遗传易感性中的作用,我们在COPD患者中研究了IL1B,IL1RN,TNFA,LTA,IL6,IL8和IL10的等位基因和基因型分布(N = 319)和健康人(N = 403),巴什科尔托斯坦共和国乌法居民。 IL1RN的基因型IL1RN * 2 / IL1RN * 2被确定为COPD的危险因素,其频率在COPD患者中为9.80%,在健康受试者中为4.67%(chi〜2 = 5.45,df = 1,P = 0.02, OR = 2.21)。 LTA多态性A252G的基因型GG在COPD患者中比在对照组中更为常见(7.84%比3.72%; chi〜2 = 5.00,df = 1,P = 0.026)。在患有COPD的IV期患者中,这种基因型的频率是患有COPD的II和III期患者的两倍(11.18%vs. 4.79%; chi〜2 = 3.08,df = 1,P = 0.08)。 COPD患者中TNFA基因多态性G(-308)A的基因型GG与LTA基因多态性A252G的基因型AA的结合显着低于健康受试者(38.55%对46.93%; chi〜2 = 8.82,df = 1,P = 0.0039)。 IL6基因多态性G(-174)C的基因型GG在COPD第四期患者中更为常见(43.75%比COPD II和III期患者的31.54%,chi〜2 = 4.15,P = 0.042)。在COPD患者和健康受试者的组之间,IL1B的多态性T(-511)C和T3953C,TNFA的G(-308)A,IL6的G(-174)C的基因型频率没有显着差异。 IL8的A(-251)C和IL10的C(-627)A。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号